dimarts, 26 de març del 2019

Johnson & Johnson touts drug-releasing lens studies for itchy eyes

Johnson & JohnsonContact lenses imbued with an antihistamine drug reduced itchy eyes in a pair of older studies funded by the vision business at Johnson & Johnson(NYSE:JNJ), the company said today.

The Phase 3 studies, conducted in 2007, involved a total of 244 patients, divided into three cohorts. In the first patients wore a plain lens made of etafilcon a in one eye and the same lens treated with 0.019mg of the drug ketotifen in the other eye. In the second group, patients wore treated lenses in both eyes; the third group was the control, consisting of patients wearing placebo lenses in both eyes. There were about 40 subjects in each group.

Get the full story at our sister site, Drug Delivery Business News.

The post Johnson & Johnson touts drug-releasing lens studies for itchy eyes appeared first on MassDevice.



from MassDevice https://ift.tt/2UX3rJ8

Cap comentari:

Publica un comentari a l'entrada